Clearing Senescent Cells Is Not the Same as Reversing Aging

Senescent cells have become one of the most recognizable targets in longevity science. These are damaged or stressed cells that enter a persistent state in which they no longer function normally and may release inflammatory and tissue-remodeling signals collectively known as the senescence-associated secretory phenotype, or SASP.

Because senescent cells accumulate with age and can contribute to chronic inflammation, fibrosis and impaired tissue repair, a seemingly straightforward idea has emerged: remove them, and perhaps the body will become younger.

This reasoning has driven interest in small-molecule senolytics, immune-based senescent-cell clearance and experimental approaches such as natural killer cell infusion. But an important mouse study published in Nature Aging highlights a limitation that is often overlooked:

Removing a downstream product of biological stress does not necessarily correct the upstream condition that produced it.

Chronic social stress produced senescent-like cells

Carey Lyons and colleagues investigated whether chronic stress could directly induce cellular senescence in mice. They compared two different forms of stress.

One was chronic restraint stress, in which mice were physically restrained for several hours each day. The other was chronic subordination stress, in which a male mouse was repeatedly exposed to aggression from a dominant mouse and then remained separated from the aggressor by a perforated barrier. Physical injury was prevented after the encounter, but the subordinate mouse continued to see, smell and hear the dominant mouse.

This second model created an environment of continuing social threat—persistent, difficult to control and difficult to escape.

The two forms of stress did not produce identical biological responses. Restraint stress increased the stress-response marker p21 in the brains of male mice but did not produce a strong p16-associated senescence pattern. Chronic social subordination, by contrast, caused a sustained rise in p16 expression in circulating immune cells and increased several senescence-associated markers in adipose tissue and the brain.

The brain appeared particularly sensitive. The strongest changes occurred in the hippocampus and cortex, where many of the p16-positive cells were neurons. These cells also showed evidence of DNA damage, inflammatory signaling and activation of pathways related to the SASP.

Remarkably, these changes appeared after only four weeks of social stress in young mice. With prolonged exposure, p16 expression in circulating cells continued to rise and became much higher than in age-matched control animals.

The study therefore provides a plausible biological bridge between chronic social adversity and accelerated aging: sustained threat can increase cellular damage and push selected cells toward a senescent-like state.

But the most informative result came from what happened when the researchers removed those cells.

The researchers cleared p16-positive cells—but the mice did not recover

The investigators used genetically modified mice in which p16-expressing cells could be selectively eliminated using ganciclovir.

The intervention worked at the cellular level. Removing p16-positive cells reduced:

• p16 and p21-associated signals

• inflammatory factors such as IL-1β and IL-6

• senescence-associated molecular patterns

• cortical DNA-damage measurements

From a conventional senolytic perspective, this looked like successful target engagement. The intended cells were removed, and several molecular abnormalities improved.

Yet the broader stress phenotype remained.

The mice continued to show hyperphagia and excessive weight gain. Stress-related changes in the hypothalamic–pituitary–adrenal axis persisted. During longer follow-up, senescent-cell clearance did not prevent increased frailty or loss of fur pigmentation.

The intervention removed part of the biological aftermath of chronic stress, but it did not restore the organism to its previous physiological state.

This does not mean that the senescent cells were irrelevant. They may still have amplified inflammation, impaired local tissue function or contributed to outcomes that were not measured. Nor does the study prove that senolytics cannot be helpful in other diseases or tissues.

What it does show is that successful clearance of senescent cells should not automatically be interpreted as reversal of the process that generated them.

Senescence may be part of an adaptive triage response

Senescence is often described simply as cellular deterioration. But it can also be understood as a protective decision made under constraint.

When a cell experiences severe or persistent damage, continuing to divide may be dangerous. Damaged DNA could be transmitted to daughter cells, potentially increasing the risk of cancer or tissue dysfunction. By stopping proliferation, the cell contains that risk.

The senescent cell may then release signals that communicate distress, recruit immune cells and promote tissue repair or remodeling. Ideally, the initiating threat resolves, the damaged cell is cleared and healthy cells rebuild the tissue.

In this sense, senescence can be viewed as a form of cellular allostatic triage:

When repair and safe proliferation are no longer feasible, the cell sacrifices its normal function to protect the wider tissue.

The problem arises when the stress remains unresolved, immune clearance becomes inadequate or regenerative capacity declines. Senescent cells then accumulate, and their signaling can become chronically inflammatory and pathogenic.

The cell is no longer merely responding to damage. It becomes part of a self-reinforcing environment that creates further damage.

What this means for senolytic interventions

Most senolytic strategies intervene near the end of this sequence:

Persistent stress or damage → impaired repair → senescence → SASP → secondary tissue dysfunction

Senolytics attempt to remove cells that have reached the senescent stage. This may reduce SASP activity and relieve one source of tissue dysfunction. But it does not necessarily correct:

• the stressor that initiated the damage

• mitochondrial or metabolic limitations

• impaired blood flow or oxygen delivery

• chronic immune activation

• autonomic and neuroendocrine dysregulation

• loss of regenerative capacity

• extracellular-matrix damage

• ongoing toxicant, infectious or nutritional pressures

If those upstream conditions remain, new cells may continue to become damaged and senescent.

Senolytic treatment may therefore lower the existing burden without meaningfully reducing the rate at which the burden is produced.

A useful conceptual relationship is:

Net senescent-cell burden = formation of new senescent cells − clearance of existing senescent cells

Most senolytic interventions increase clearance. But aging and chronic disease may also require us to address the other side of the equation: why cells are entering senescence in the first place.

The same caution applies to NK-cell infusion

Natural killer cells are part of the immune system’s surveillance and clearance machinery. They can recognize and eliminate some abnormal, infected or stressed cells, and researchers are investigating whether their activity can be directed or enhanced against senescent cells.

This has led to interest in NK-cell infusion as a potential senotherapeutic or longevity intervention.

Conceptually, however, NK-cell infusion encounters the same limitation as other senolytic approaches.

Even when infused NK cells successfully identify and remove some senescent cells, they do not automatically restore mitochondrial function, repair damaged tissue, normalize stress physiology or eliminate the environmental and metabolic pressures that caused cellular damage.

Their effect may also depend on whether:

• the relevant senescent cells display recognizable surface signals

• NK cells can reach the affected tissue

• the infused cells remain metabolically functional

• inhibitory signals within the tissue suppress immune killing

• sufficient regenerative capacity exists after the damaged cells are removed

Clearance creates an opportunity for recovery. It does not guarantee that recovery can occur.

For example, removing damaged cells from an aged tissue may be beneficial when healthy progenitor cells, adequate circulation and sufficient bioenergetic reserve remain available to rebuild it. The same clearance may produce limited improvement if the tissue lacks stem-cell capacity, blood supply, nutrients or mitochondrial energy to regenerate.

NK-cell infusion might therefore become useful for reducing selected senescent-cell populations or treating particular senescence-driven conditions. But describing it as an intervention that reverses aging would go far beyond what this mechanism alone can reasonably accomplish.

A bioenergetic impedance perspective

From our bioenergetic impedance perspective, aging is not simply the accumulation of defective components. It reflects a progressive difficulty in transforming available energy and resources into effective adaptation, repair and recovery.

The body may still contain fuel, oxygen and nutrients, yet encounter resistance in moving these resources through the processes that require them. Mitochondrial throughput may become constrained. Redox balance may become difficult to restore. Inflammatory and neuroendocrine activation may remain switched on. Repair may be initiated but not completed.

Under these conditions, cells face an increasingly difficult choice. They may reduce activity, alter metabolism, enter senescence or undergo regulated cell death. These states are not necessarily independent causes of aging. They may be different outcomes of the same unresolved bioenergetic constraint.

Senescent cells can then intensify the impedance by releasing inflammatory signals, disturbing neighboring cells and increasing the energetic cost of tissue maintenance. They become both a consequence and an amplifier of the underlying problem.

This creates a cycle:

Persistent demand → constrained energy transformation → incomplete repair → cellular senescence → inflammatory amplification → greater bioenergetic impedance

Senolytics interrupt one part of that cycle. They may remove an important amplifier. But unless demand, throughput, buffering and recovery are also addressed, the system may remain trapped in the same physiological configuration.

Clearance is not reconstruction

A useful analogy is removing damaged buildings after a disaster.

Demolition may eliminate unstable structures and make the area safer. But it does not rebuild roads, restore electricity, deliver construction materials or provide the labor needed for reconstruction.

Senolysis is the demolition phase.

Recovery still requires:

• resolution of the original threat

• adequate energy production

• functional circulation and transport

• immune coordination

• material and nutrient availability

• regenerative cells

• time for rebuilding

This distinction helps explain why a senolytic can produce clear molecular changes without producing equally dramatic improvements in whole-body function.

It also suggests that senolytics may work best when three conditions are present: senescent cells have become an important independent driver of pathology, the upstream source of injury has been reduced, and sufficient physiological reserve remains to regenerate the tissue after clearance.

A more realistic view of senolytics

Senolytics should not be dismissed. In the right context, reducing a pathogenic senescent-cell population may relieve inflammation, improve tissue function or slow progression of a specific disease.

But the language matters.

Removing senescent cells is not necessarily rejuvenation. Reducing a hallmark of aging is not the same as reversing the integrated network state that produced it. And improvement in a biomarker does not prove restoration of adaptive capacity.

The study by Lyons and colleagues provides an especially clear example. Chronic social stress generated DNA-damaged, p16-positive cells. Removing those cells reduced several molecular signs of senescence—but the stressed organism remained metabolically and physiologically altered.

The deeper lesson is that aging cannot be understood only by identifying damaged components and eliminating them. We must also ask why damage continues to arise, why repair remains incomplete and whether the organism still possesses the energy, coordination and reserve required to rebuild.

Senescent-cell clearance may remove part of the burden.

Reversing the conditions that continuously generate that burden is the more fundamental challenge.

Lyons, C. E., Pallais, J. P., McGonigle, S., Mansk, R. P., Collinge, C. W., Yousefzadeh, M. J., Baker, D. J., Schrank, P. R., Williams, J. W., Niedernhofer, L. J., van Deursen, J. M., Razzoli, M., & Bartolomucci, A. (2025). Chronic social stress induces p16-mediated senescent cell accumulation in mice. Nature Aging, 5(1), 48–64. https://doi.org/10.1038/s43587-024-00743-8